Jordan S. Davis is a Managing Partner and co-founder of Radius, which acts as the Investment Advisor to the Radius Funds. Jordan’s experience spans the founding of new ventures to growth capital stage investing in a broad range of innovative healthcare, medical technology and life sciences companies. The most critical part of Jordan's job is to add value to his investments, providing judgment, deal-making expertise and C-Level access to firm’s deep and vast network of industry relationships that have often proven to result in "game-changing" opportunities.

Having begun his career at Morgan Stanley & Co., Jordan brings capital markets expertise and perspective to Radius’ portfolio companies as they navigate alternative financing paths and strategic options. Prior to Radius, Jordan was a Managing Director at KBL Healthcare, Inc., a venture capital and investment banking firm, where he co-founded and served as Vice President and board member of KBL Healthcare Acquisition Corp. (KBL), a publicly traded acquisition vehicle designed to provide an alternative means for an emerging private healthcare company to access vital growth capital. KBL successfully merged with Concord Health Group, a rapidly growing long-term care provider, where Jordan continued to serve as a board member until its ultimate acquisition by The Multicare Companies.

As an entrepreneur, Jordan was a founder of Cambridge Heart, Inc., a cardiology device company that developed and commercialized breakthrough technology to non-invasively diagnose patients at risk of sudden cardiac death, and Voxware, Inc., an early entrant and pioneer in the voice over IP market; both of these companies moved from start-up to IPO in three years.

Jordan brings his expertise, entrepreneurial creativity, vision and passion to the Radius portfolio companies, having led investments in companies including Athersys (Reverse IPO; NASDAQ: ATHX), BioStorage Technologies (acquired by Brooks Automation), BEI Medical Systems (acquired by Boston Scientific), Conor Medsystems (acquired by J&J), Medingo (acquired by Roche), Health Language (acquired by Wolters Kluwer) and Tactile Medical (IPO; NASDAQ: TCMD). 

He has served on numerous private and public company boards and currently serves on the board of directors of Pathnostics, a leading precision diagnostics company initially focused on its breakthrough Guidance® UTI Test to both rapidly diagnosis and enable effective, timely treatment of UTI infections. Jordan also serves on the Advisory Board of HealthCorps, a national non-profit peer mentoring organization dedicated to educating and empowering youth to take charge of their health.

Jordan earned an M.B.A. from the Kellogg School of Management at Northwestern University and a B.A. in Economics from The State University of New York at Binghamton.